celecoxib has been researched along with Mastocytosis, Systemic in 1 studies
Mastocytosis, Systemic: A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moreno-Borque, R | 1 |
| Matito, A | 1 |
| Álvarez-Twose, I | 1 |
| Morgado, JM | 1 |
| Sánchez-Muñoz, L | 1 |
| Orfao, A | 1 |
| Escribano, L | 1 |
1 other study available for celecoxib and Mastocytosis, Systemic
| Article | Year |
|---|---|
Response to celecoxib in a patient with indolent systemic mastocytosis presenting with intractable diarrhea.
Topics: Celecoxib; Cyclooxygenase 2 Inhibitors; Diarrhea; Female; Humans; Mastocytosis, Systemic; Middle Age | 2015 |